Sarah James
Stock Analyst at Cantor Fitzgerald
(0)
# 4105
Out of 5,240 analysts
286
Total ratings
23.30%
Success rate
-6.21%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Centene | Reiterates: Overweight | 90 90 | 63.44 | 41.87% | 12 | Dec 11, 2024 | |
Acadia Healthcare Co | Reiterates: Neutral | 52 52 | 44.29 | 17.41% | 13 | Dec 10, 2024 | |
Progyny | Maintains: Overweight | 30 17 | 20.08 | -15.34% | 14 | Nov 14, 2024 | |
Tenet Healthcare | Maintains: Overweight | 168 177 | 127.51 | 38.81% | 19 | Oct 30, 2024 | |
Universal Health Ser... | Reiterates: Neutral | 219 219 | 183.86 | 19.11% | 24 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 406 406 | 294.24 | 37.98% | 11 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 400 400 | 284.87 | 40.41% | 19 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 600 485 | 392.95 | 23.43% | 18 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 591 644 | 543.03 | 18.59% | 16 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 13 13 | 21.31 | -39% | 5 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 43 43 | 19.86 | 116.52% | 12 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 15 15 | n/a | n/a | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 16 16 | 5.88 | 172.11% | 6 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 392 392 | 305.87 | 28.16% | 18 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 395 395 | 282.58 | 39.78% | 19 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 62 62 | 51.58 | 20.2% | 14 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 15 15 | 4.72 | 217.8% | 10 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 5 5 | 4.07 | 22.85% | 8 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 9.35 | 6.95% | 2 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 101 101 | 92 | 9.78% | 7 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Equal-Weight | 133 | 162.01 | -17.91% | 6 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 42 | 16.89 | 148.67% | 3 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 5 | 3.65 | 36.99% | 2 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 7 5 | 4.51 | 10.86% | 2 | Aug 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 31 34 | n/a | n/a | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 50 57 | n/a | n/a | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 21 | 13.47 | 55.9% | 3 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 15 18 | n/a | n/a | 2 | Jul 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 39 | 65.56 | -40.51% | 1 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 212 206 | n/a | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 151 0 | n/a | n/a | 2 | Jan 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 193 | 71.25 | 170.88% | 2 | Sep 15, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | n/a | n/a | n/a | 2 | Mar 1, 2017 |